Abbott released interim clinical study data on ID NOW COVID-19 rapid test showing strong agreement to lab-based molecular PCR tests
On May 21, 2020, Abbott announced an interim analysis of an ongoing multi-site clinical study in urgent care…
On May 21, 2020, Abbott announced an interim analysis of an ongoing multi-site clinical study in urgent care…
On May 21, 2020, AstraZeneca announced it was advancing its response to address the unprecedented challenges of COVID-19,…
On May 21, 2020, BioAegis Therapeutics announced that the National Institute of Health Clinical Center began measuring patient…
On May 21, 2020, Roche announced that it had acquired Seattle-based Stratos Genomics, an early-stage sequencing technology company…
On May 20, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the closing of a $10.8 million…
On May 20, 2020, CHF Solutions announced a publication highlighting the use of ultrafiltration for fluid management of…
On May 20, 2020, Airway Therapeutics and Celonic Group announced a collaboration to produce the novel human recombinant…
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
On May 19, 2020, the University of Oxford announced the release of the T-SPOT Discovery SARS-CoV-2 test kit….
On May 19, 2020, a University of Southern California (USC) study reported results from the first phase of…
On May 19, 2020, in a study published in Cell Reports, researchers at the University of Hong Kong…
On May 19, 2020, Phlow, a U.S.-based, public benefit drug manufacturing corporation, received federal government funding of $354…
On May 19, 2020, CytoDyn announced it will be coordinating with the National Institution of Health of Mexico…
On May 18, 2020, the NIH reported that roughly 3 to 5% of children with an aunt or…
On May 18, 2020, an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks…
On May 18, 2020, Quidel announced it had received Emergency Use Authorization (EUA) for the Lyra Direct SARS-CoV-2…
On May 18, 2020, Moderna announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus…
On May 15, 2020, the California Institute for Regenerative Medicine (CIRM) board approved new clinical trials for COVID-19…
On May 14, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that a clinical trial…
On May 14, 2020, CureVac announced positive pre-clinical results at a low dose for its lead vaccine candidate…
On May 14, 2020,The Scientist reported that researchers from several countries including the US, Switzerland, Italy, the Netherlands,…
On May 14, 2020 Abivax announced that ABX464 inhibited replication of SARS-CoV-2 in an in vitro reconstituted human…
On May 13, 2020, Thermo Fisher Scientific announced it will expand its response to the COVID-19 pandemic by…
On May 13, 2020, in a study published in the New England Journal of Medicine, scientists in the…
On May 12, 2020, the National Research Council of Canada (NRC) announced a collaboration with CanSino Biologics to…
On May 12, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had accepted a donation of…
On May 12, 2020, University of British Columbia Professor Amanda Vincent, the first biologist to study seahorses in…
On May 12, 2020, the Jackson Laboratory (JAX), in partnership with the State of Connecticut, announced that it…
On May 12, 2020, Moderna announced the U.S. Food and Drug Administration (FDA had granted Fast Track designation…
On May 11, 2020, a study was published in JAMA Network that attempts to answer the question whether…